Abstract:In this report, we evaluated the efficiency of stable gene transfer into established CD8(+) human tumor antigen-specific cytotoxic T cell (CTL) lines and peripheral blood lymphocytes (PBL) by oncoretroviral and lentiviral vectors. In the oncoretroviral vector, the green fluorescent protein (GFP) reporter gene was regulated by the murine stem cell virus (MSCV) promoter. In three human immunodeficiency virus type 1 (HIV-1)-based lentiviral vectors, the GFP transgene was regulated by either a chimeric MSCV/HIV-1 promoter, or cellular promoters from human housekeeping genes PGK and EF1alpha. We found that several lines of proliferating tumor-specific CTL were poorly (=2%) transduced by the oncoretroviral vector that transduced Jurkat T cell line efficiently (=80%). In contrast, three lentiviral vectors transduced 38 - 63% of these proliferating CTL. More interestingly, all lentiviral vectors packaged without the HIV-1 accessory proteins transduced human bulk PBL and purified CD4(+) and CD8(+) lymphocyte subsets without prior stimulation. Detailed analysis indicated that the lentiviral vectors containing the EF1a or PGK ubiquitous promoter can transduce unstimulated PBL and achieve low-level transgene expression in the absence of any T-cell activation. However, T-cell activation subsequent to the transduction of unstimulated PBL is required for high-level transgene expression. Transduced PBL expressing transgene delivered by the lentiviral vectors still preserved resting and naive cell phenotypes. Taken together, prior T cell stimulation and HIV-1 accessory proteins are dispensable for lentivirus-mediated gene transfer into resting naive and memory T lymphocytes. These results will have significant implications for the study of T-cell biology and for the improvement of clinical gene therapies of acquired immune deficiency syndrome (AIDS) and cancer.

Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement

Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells.

Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors

[33] Oncoretroviral and lentiviral vector-mediated gene therapy

[29] Transduction of a gene expression cassette using advanced generation lentiviral vectors

Lentiviruses as gene transfer agents for delivery to non-dividing cells

62. Proteasome Activity Restricts Lentiviral Gene Transfer into Hematopoietic Stem Cells and Is Down-Regulated by Cytokines That Enhance Transduction

[26] Generation of HIV-1 derived lentiviral vectors

Development of Endothelial-Specific Single Inducible Lentiviral Vectors for Genetic Engineering of Endothelial Progenitor Cells

Cellular innate immunity and restriction of viral infection: implications for lentiviral gene therapy in human hematopoietic cells

A Self-Deletion Lentiviral Vector to Reduce the Risk of Replication-Competent Virus Formation

High‐Level Sustained Transgene Expression in Human Embryonic Stem Cells Using Lentiviral Vectors

In vivo gene delivery by lentiviral vectors

Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences

Lentivirus-Mediated Gene Transfer and Expression in Established Human Tumor Antigen-Specific Cytotoxic T Cells and Primary Unstimulated T Cells

Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells

Optimization of a lentivirus-mediated gene therapy targeting HIV-1 RNA to eliminate HIV-1-infected cells

Lentiviral Delivery of Proteins for Genome Engineering

Retroviral hybrid LTR vector strategy: functional analysis of LTR elements and generation of endothelial cell specificity

A Single-Ltr HIV-1 Vector Optimized for Functional Genomics Applications

Zinc finger protein designed to target 2-long terminal repeat junctions interferes with human immunodeficiency virus integration